by Peter Ciszewski | Mar 12, 2021
Emily Holtvluwer discusses the gene therapy her two children with spinal muscular atrophy (SMA) have received. As Ms. Hotvluwar explains, her oldest child was diagnosed several months after symptoms began to appear while her second child was diagnosed in...
by Peter Ciszewski | Mar 11, 2021
Michael Hocquemiller, PhD, and Samantha Parker of Lysogene talk about the latest developments in the company’s gene therapy, LYS-SAF302, to treat Sanfilippo syndrome type A. Sanfilippo syndrome type A (MPS IIIA) is a progressive, life-threatening, and rare...
by Peter Ciszewski | Mar 11, 2021
Regina Phillips, mother of a young child diagnosed with spinal muscular atrophy (SMA), talks about the 4 month journey to get properly diagnosed with this rare neuromuscular disorder. As Ms. Phillips explains, her son, Shane, was born looking very happy and...
by Peter Ciszewski | Mar 10, 2021
Melanie McKay, mother of a young boy with infantile-onset Pompe disease talks about the importance of having a clinician listen to the caregiver of the child. Pompe disease is a rare inherited lysosomal storage disorder due to low levels of acid...
by Peter Ciszewski | Mar 10, 2021
Francesca Fumagalli, PhD, Researcher of Cardiovascular Medicine at Istituto di Ricerche Farmacologiche Mario Negri (IRCCS), discusses positive results of a study of lentiviral hematopoietic stem cell gene therapy for the treatment of metachromatic...